The Texas A&M Health Science Center (TAMHSC) has officially welcomed a new member to its faculty of acclaimed educators — pediatric pulmonologist and researcher Carolyn Cannon, M.D., Ph.D. Dr. Cannon is credited for creating innovative treatment options for pediatric respiratory diseases.
Previously at Dallas’ University of Texas Southwestern Medical Center, Dr. Cannon formerly held the position of director of the Pediatric Cystic Fibrosis Center and Pediatric Pulmonology Fellowship Training Program. She is currently TAMHSC’s newest recruit for its Bryan campus.
Aside from mentoring TAMHSC’s medical and doctorate students in Houston, she will also be offering her services to patients at the Texas Children’s Hospital in the Texas Medical Center. Dr. Cannon will also be taking on leadership roles under the center’s recent Healthy South Texas initiative.
At present, Dr. Cannon is a member of the National Heart, Lung, and Blood Institute Center for Integrated Nanosystems for Diagnosis and Therapy, which is headed by W.T. Doherty-Welch Chair of TAMU’s Department of Chemistry, Karen L. Wooley, Ph.D. Their more recent works have been focused on children afflicted with cystic fibrosis.
Brett P. Giroir, M.D., the CEO of TAMHSC, said that the collaboration between Cannon and Wooley will create new opportunities for Texas A&M in the field of health-centered research and development. Cannon’s addition to their already impressive faculty only bolsters their mission to become one of the country’s most innovative research centers for health sciences.
Aside from welcoming a fresh member to the TAMHSC faculty, the center has also been reported to be a potential site for the mass-production of a trial Ebola drug, if needed.